OpenAI has recently released its first AI agent, Operator. But how is it different from the ChatGPT platform? Let's find out.
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
The prime minister’s bumbling answer to a press club question on Australia’s engagement in the AI arms race shows how ...
More orders are expected Tuesday amid fallout from his first moves, including his issuing pardons for more than a thousand ...
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Chinese start-up DeepSeek is as powerful as ChatGPT and purportedly uses much less computing power. Will this competition ...
According to a recent research report from Goldman Sachs, AI could boost global growth by 7% over the next decade, boost S&P ...